ABOS Competitors & Alternatives
Compare Acumen Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
ABOS
Main Stock$1.99
Tradestie Score
60
Market Cap
$106.00M
Analyst Upside
+281.9%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ACRS
Aclaris Therapeutics, Inc.
|
$3.81
|
$202.58M | - | 64 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.99
|
$180.53M | - | 54 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$6.77
|
$170.45M | - | 42 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.46
|
$158.43M | - | 59 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$20.04
|
$154.27M | - | 43 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.22
|
$133.50M | - | 63 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$5.45
|
$114.01M | - | 63 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$21.86
|
$110.20M | - | 57 | Compare |
|
ALXO
ALX Oncology Holdings Inc. Common Stock
|
$1.17
|
$96.93M | - | 58 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$2.89
|
$84.52M | - | 42 | Compare |
More ABOS Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2836)
222 stocks in this industry